Coherus Oncology, Inc. (CHRS)
0.99
-0.08
(-7.48%)
USD |
NASDAQ |
Oct 16, 16:00
1.01
+0.02
(+2.02%)
After-Hours: 20:00
Coherus Oncology Cash and Short Term Investments (Quarterly) : 105.31M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 105.31M |
| March 31, 2026 | 167.05M |
| December 31, 2025 | 172.12M |
| September 30, 2025 | 191.66M |
| June 30, 2025 | 237.64M |
| March 31, 2025 | 82.41M |
| December 31, 2024 | 125.99M |
| September 30, 2024 | 97.69M |
| June 30, 2024 | 159.24M |
| March 31, 2024 | 259.78M |
| December 31, 2023 | 117.75M |
| September 30, 2023 | 131.53M |
| June 30, 2023 | 145.15M |
| March 31, 2023 | 128.53M |
| December 31, 2022 | 191.68M |
| September 30, 2022 | 287.24M |
| June 30, 2022 | 275.92M |
| March 31, 2022 | 326.12M |
| December 31, 2021 | 417.20M |
| September 30, 2021 | 468.71M |
| June 30, 2021 | 454.42M |
| March 31, 2021 | 399.50M |
| December 31, 2020 | 541.16M |
| September 30, 2020 | 503.43M |
| June 30, 2020 | 456.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 193.25M |
| December 31, 2019 | 177.67M |
| September 30, 2019 | 170.54M |
| June 30, 2019 | 111.97M |
| March 31, 2019 | 96.48M |
| December 31, 2018 | 72.41M |
| September 30, 2018 | 117.22M |
| June 30, 2018 | 159.87M |
| March 31, 2018 | 95.21M |
| December 31, 2017 | 126.97M |
| September 30, 2017 | 150.11M |
| June 30, 2017 | 118.39M |
| March 31, 2017 | 174.88M |
| December 31, 2016 | 125.01M |
| September 30, 2016 | 159.74M |
| June 30, 2016 | 220.98M |
| March 31, 2016 | 179.62M |
| December 31, 2015 | 158.29M |
| September 30, 2015 | 153.75M |
| June 30, 2015 | 206.15M |
| March 31, 2015 | 115.20M |
| December 31, 2014 | 150.45M |
| September 30, 2014 | 100.92M |
| June 30, 2014 | 108.92M |
| March 31, 2014 | 56.37M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Enanta Pharmaceuticals, Inc. | 189.51M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |